In order to bring real efficiency while keeping patients safe, the only answer is risk-based optimization.
TORONTO, Ontario (PRWEB) November 20, 2020
Clinical trial optimization and clinical trial forecasting are often confused with one another, but mixing up the two approaches can bring dangerous results when managing a clinical supply chain.
Clinical trial optimization that is risk-based delivers many benefits, including ensuring 100 percent patient service levels and more efficient planning. It also brings information for fact-based decision making to the table in comparison with clinical supply forecasting tools. In order to bring real efficiency while keeping patients safe, the only answer is risk-based optimization.
Join experts from N-SIDE, Amaury Jeandrain, Head of Life Sciences Solutions Adoption; and Antoine Remoit, Senior Consultant, for a live webinar on Monday, December 7, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit Risk-Based Optimization or Forecasting? The Impact On Clinical Trial Supply Planning.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
